Alane P Barnes Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Alane P Barnes is Chief Legal Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 398,751 shares of BCRX, which is worth approximately $2.82 Million. The most recent transaction as insider was on Dec 22, 2025, when has been sold 21,773 shares (Common Stock) at a price of $7.65 per share, resulting in proceeds of $166,563. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 399K

3.39% 3M change

3.39% 12M change

Total Value Held $2.82 Million

Alane P Barnes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2025	SELL Open market or private sale	$166,563 $7.65 p/Share	21,773 Reduced 5.18%	398,751 Common Stock
Dec 19 2025	SELL Payment of exercise price or tax liability	$125,243 $7.41 p/Share	16,902 Reduced 3.86%	420,524 Common Stock
Dec 17 2025	BUY Grant, award, or other acquisition	-	121,700 Added 21.77%	437,426 Common Stock
Dec 15 2025	SELL Open market or private sale	$162,256 $7.65 p/Share	21,210 Reduced 6.29%	315,726 Common Stock
Dec 12 2025	SELL Payment of exercise price or tax liability	$64,647 $7.57 p/Share	8,540 Reduced 2.47%	336,936 Common Stock
Dec 03 2025	SELL Open market or private sale	$151,240 $7.65 p/Share	19,770 Reduced 5.41%	345,476 Common Stock
Dec 02 2025	SELL Open market or private sale	$367,032 $7.21 p/Share	50,906 Reduced 12.23%	365,246 Common Stock

Dec 01 2025	SELL Open market or private sale	$646,128 $7.1 p/Share	91,004 Reduced 17.94%	416,152 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	$293,032 $3.22 p/Share	91,004 Added 15.21%	507,156 Common Stock
Dec 19 2024	SELL Payment of exercise price or tax liability	$18,186 $7.39 p/Share	2,461 Reduced 0.59%	412,729 Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	120,700 Added 22.52%	415,190 Common Stock
Dec 14 2024	SELL Payment of exercise price or tax liability	$64,855 $7.53 p/Share	8,613 Reduced 2.84%	294,490 Common Stock
May 13 2024	BUY Open market or private purchase	$27,650 $5.53 p/Share	5,000 Added 1.64%	300,762 Common Stock
Dec 19 2023	SELL Payment of exercise price or tax liability	$15,016 $6.05 p/Share	2,482 Reduced 0.84%	293,539 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$25,816 $6.43 p/Share	4,015 Reduced 1.34%	296,021 Common Stock
Dec 14 2023	BUY Grant, award, or other acquisition	-	64,000 Added 17.58%	300,036 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	34,000 Added 12.75%	232,770 Common Stock
Dec 15 2022	SELL Open market or private sale	$45,424 $10.88 p/Share	4,175 Reduced 2.06%	198,770 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	75,000 Added 25.26%	221,969 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$169,580 $4.73 p/Share	35,852 Added 19.7%	146,127 Common Stock
May 11 2021	SELL Open market or private sale	$1,237,471 $12.04 p/Share	102,780 Reduced 48.24%	110,275 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$397,759 $3.87 p/Share	102,780 Added 32.54%	213,055 Common Stock
Dec 11 2020	SELL Open market or private sale	$109,378 $7.96 p/Share	13,741 Reduced 11.28%	108,061 Common Stock
Dec 11 2020	BUY Exercise of conversion of derivative security	$57,025 $4.15 p/Share	13,741 Added 10.14%	121,802 Common Stock
Dec 04 2020	SELL Open market or private sale	$85,606 $6.23 p/Share	13,741 Reduced 11.28%	108,061 Common Stock

APB

Alane P Barnes

Chief Legal Officer

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account